|
 |
 |
| ||||||||||||||
|
 |
 |
|
 | ||
 | ||
| ||
 | ||
|
 | |
 | |
 |
Over the years, Pharmascience has established a solid reputation as a major industry player known for our expertise in developing top-quality products, combined with highly-efficient marketing and sales strategies. This has allowed Pharmascience to form strategic licensing agreements with such recognized leaders as Alcon, Astra Zeneca, Abbott, Berlex, Bristol-Myers Squibb, Fournier, Janssen-Ortho, Eli-Lilly, Novartis, Purdue and Roche. Characteristic of our commitment to leadership, collaboration and innovation, Pharmascience was commissioned by Eli Lilly to market its generic brand of Prozac® four months before its patent expired. This allowed Eli Lilly to retain the lion's share of the fluoxetine market in Canada, despite fierce competition from numerous manufacturers, and demonstrated Pharmascience's continuous ability to "create the difference". |
